Mammographic Screening and Risk Factors for Breast Cancer
被引:51
|
作者:
Cook, Nancy R.
论文数: 0引用数: 0
h-index: 0
机构:
Brigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02215 USA
Harvard Univ, Sch Med, Boston, MA USA
Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USABrigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02215 USA
Cook, Nancy R.
[1
,2
,4
]
Rosner, Bernard A.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Boston, MA USA
Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02215 USA
Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USABrigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02215 USA
Rosner, Bernard A.
[2
,3
,5
]
Hankinson, Susan E.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Boston, MA USA
Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02215 USA
Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USABrigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02215 USA
Hankinson, Susan E.
[2
,3
,4
]
Colditz, Graham A.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
Washington Univ, Sch Med, St Louis, MO USABrigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02215 USA
Colditz, Graham A.
[4
,6
]
机构:
[1] Brigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02215 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[5] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
breast neoplasms;
hormone replacement therapy;
mammography;
mass screening;
probability weighting;
risk factors;
RANDOMIZED CONTROLLED-TRIAL;
ESTROGEN PLUS PROGESTIN;
POSTMENOPAUSAL WOMEN;
REPLACEMENT THERAPY;
HEALTH;
MODEL;
EPIDEMIOLOGY;
MORTALITY;
BENEFITS;
RACE;
D O I:
10.1093/aje/kwp304
中图分类号:
R1 [预防医学、卫生学];
学科分类号:
1004 ;
120402 ;
摘要:
Screening mammography can distort estimated effects in breast cancer risk models due to associations with other risk factors. Mammography information was available in the Nurses' Health Study from 1988, and 1,815 incident breast cancers were accrued through 2000 among 55,625 women with risk factor data. Logistic models were fit for screening mammography, and inverse probability weighting was used to adjust parameters in an established breast cancer risk model. Approximately 80% of women in each 2-year follow-up period had screening mammograms, which were positively associated with history of benign breast disease, family history of breast cancer, hormone therapy, alcohol use, physical activity, multivitamins, and calcium supplements, and negatively associated with postmenopause, current smoking, and body mass index. Markers of medical attention, including hypertension, high cholesterol, and osteoarthritis, were positively associated, while cardiovascular disease was negative. Inverse probability weighting led to small changes in effects of benign breast disease, family history, and hormone therapy. An apparent reduced risk associated with current smoking in unadjusted models was eliminated after weighting. Thus, several risk factors for breast cancer and cancer diagnosis are associated with mammographic screening. Adjustment for screening had some impact on breast cancer prediction in this cohort, especially for hormone therapy and smoking.